JNJ-4355 | m-entrepreneurship.com

Product Name :
JNJ-4355

Search keywords :
JNJ-4355

drugId :
null

Target Vo:
Induced myeloid leukemia cell differentiation protein Mcl-1

Target Vo Short Name :
MCL1

Moa_Name:
Induced myeloid leukemia cell differentiation protein Mcl-1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Johnson & Johnson

Active Company_Name :
Johnson & Johnson

Active Indication_Name:
Leukemia

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
YB1 Antibody (YA004)
PKC beta 2 Antibody
Fascin Antibody: Fascin Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 55 kDa, targeting to Fascin. It can be used for WB,IHC-F,IHC-P,ICC/IF,FC,IP assays with tag free, in the background of Human, Mouse, Rat, Monkey.

Author: Betaine hydrochloride

Related Posts